Synexa Life Sciences
PrivateCompany Overview
Synexa Life Sciences is a biotechnology company that provides specialized biomarker and bioanalytical services to support clinical trials and drug development for biopharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synexa Life Sciences Comparables
Compare Synexa Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KCAS Bioanalytical and Biomarker Services | 82% | |
| BioAgilytix | 82% | |
| Resolian | 82% |
Synexa Life Sciences Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Synexa Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Industrial Development Corporation of South Africa | VC Round |
| Gilde Healthcare | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 39% MoM.
- Feb 25, 2025
Monthly visitors grew 121% MoM, reaching 2.1K.
Synexa Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synexa Life Sciences's valuation, stock price, and market status.
Is Synexa Life Sciences a public or private company?
Synexa Life Sciences is a private company.
What is the current stock price of Synexa Life Sciences?
Synexa Life Sciences is a private company, so its shares have no public market price. Caplight tracks Synexa Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synexa Life Sciences worth (valuation)?
Valuation information for Synexa Life Sciences is not publicly available.
Can I buy Synexa Life Sciences stock?
Synexa Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synexa Life Sciences's last funding round?
Funding round information for Synexa Life Sciences is not publicly available.
Who are the main investors in Synexa Life Sciences?
Key investors in Synexa Life Sciences include Gilde Healthcare.
Will Synexa Life Sciences IPO soon?
No public IPO plans have been announced for Synexa Life Sciences.
How can I track Synexa Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Synexa Life Sciences's shares on secondary markets.